2027 ICD-10-CM Diagnosis Code T65.853Toxic effect of medetomidine, assault
T65.853 is a non-billable ICD-10-CM category code for toxic effect of medetomidine, assault, so it cannot be submitted on claims. Use a more specific code from this category instead, such as T65.853A, T65.853D, and T65.853S.
Code Identity
Code Classification
Specific Coding for Toxic effect of medetomidine, assaultOverview
Coding GuidelinesGuidance
The appropriate 7th character is to be added to each code from block Toxic effect of other and unspecified substances (T65). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to T65.853: its own notes plus those printed at T65.85, T65, block T51-T65, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- contact with and (suspected) exposure to toxic substances (Z77.-)
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code to identify any retained foreign body, if applicable (Z18.-)
Notes
General instructions on how these codes are used.
- When no intent is indicated code to accidental. Undetermined intent is only for use when there is specific documentation in the record that the intent of the toxic effect cannot be determined.
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
7th Character
Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.
- The appropriate 7th character is to be added to each code from category T65
- Ainitial encounter
- Dsubsequent encounter
- Ssequela
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Clinical InformationClinical
Medetomidine
an agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. it is the racemate of dexmedetomidine.
Table of Drugs and ChemicalsClinical
Code HistoryHistory
Questions About T65.853Overview
What is the ICD-10 code for toxic effect of medetomidine, assault?
T65.853 (sometimes written as T65853) is the ICD-10-CM category for toxic effect of medetomidine, assault, but it is a non-billable header: claims need a more specific code from this category, listed on this page.
Is T65.853 (Toxic effect of medetomidine) a billable code?
No. This is a category header that groups the codes for toxic effect of medetomidine, assault, and headers cannot be submitted on claims. Claims for toxic effect of medetomidine, assault need a more specific code from this category, such as T65.853A, T65.853D, and T65.853S.
Can T65.853 be reported with a code from Z77?
Not as a rule. The Excludes1 note at block T51-T65, which applies to T65.853, lists "contact with and (suspected) exposure to toxic substances (Z77.-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
Does T65.853 need an additional code?
When the condition applies, yes. The Use Additional Code note at T65.85, which applies to T65.853, reads: code to identify associated manifestations, such as: bradycardia NOS (R00.1); somnolence, stupor and coma (R40.-). The additional code is reported after T65.853.